Characteristics of treated and nontreated hepatitis C virus–infected patients
| Parameter . | Treated (n = 15) . | Nontreated (n = 14) . | P . |
|---|---|---|---|
| Mean age, y | 51 ± 10 | 65 ± 6 | .0001 |
| Sex (male, female) | 8, 7 | 7, 7 | NS |
| Liver biopsy (%) | 15 (100) | 9 (64) | .01 |
| Cirrhosis (%) | 3 (20) | 9 (64) | .01 |
| Cryoglobulin (%) | 13 (87) | 9 (64) | NS |
| Mean cryocrit, % | 5.8 ± 8.7 | 3.17 ± 3.1 | NS |
| Abnormal ALT (%) | 13 (87) | 12 (86) | NS |
| Mean ALT, IU/L | 101 ± 60 | 86 ± 44 | NS |
| Genotype 1 (%) | 8/13 (66) | 6/8 (75) | NS |
| Mean duration of HCV infection, y* | 16.5 ± 9 | 19.6 ± 6 | NS |
| Parameter . | Treated (n = 15) . | Nontreated (n = 14) . | P . |
|---|---|---|---|
| Mean age, y | 51 ± 10 | 65 ± 6 | .0001 |
| Sex (male, female) | 8, 7 | 7, 7 | NS |
| Liver biopsy (%) | 15 (100) | 9 (64) | .01 |
| Cirrhosis (%) | 3 (20) | 9 (64) | .01 |
| Cryoglobulin (%) | 13 (87) | 9 (64) | NS |
| Mean cryocrit, % | 5.8 ± 8.7 | 3.17 ± 3.1 | NS |
| Abnormal ALT (%) | 13 (87) | 12 (86) | NS |
| Mean ALT, IU/L | 101 ± 60 | 86 ± 44 | NS |
| Genotype 1 (%) | 8/13 (66) | 6/8 (75) | NS |
| Mean duration of HCV infection, y* | 16.5 ± 9 | 19.6 ± 6 | NS |
NS indicates statistically nonsignificant; ALT, alanine aminotransferase; HCV, hepatitis C virus.
Time from the occurrence of potential risk factor for HCV infection to the detection of immunoglobulin heavy-chain gene rearrangement or bcl-2 translocation.